nˈæʃənəl kˈɪdni faʊndˈeɪʃən tˈuː θˈaʊzənd twˈɛlv ˈʌpdeɪt klˈeɪmz ðæt ɡlɪklˈeɪzaɪd dʌznˌɑːt ɹᵻkwˈaɪɚ dˈoʊsɪdʒ ˌʌp taɪtɹˈeɪʃən ˈiːvən ɪn ˈɛnd stˈeɪdʒ kˈɪdni dɪzˈiːz.
National Kidney Foundation (2012 Update) claims that Gliclazide does not require dosage up titration even in end stage kidney disease.